Psychedelics
Soft Reboot Wellness’ Ketamine Depression Treatment Now Available for Los Altos
Soft Reboot Wellness’ recently updated ketamine therapy provides clients with a precisely controlled and individualized course of treatment for persistent…
Soft Reboot Wellness’ recently updated ketamine therapy provides clients with a precisely controlled and individualized course of treatment for persistent mental health problems. The center’s premises offer a peaceful setting right in the heart of the Bay Area, equipped with the latest technology to ensure comfortable and safe infusions for all patients.
Following the latest move, Soft Reboot Wellness seeks to help more patients take advantage of ketamine therapy, which is gathering new momentum within the mental health community. At low doses, this medication can ease and reverse the symptoms of stress, revitalizing the essential neurotransmitters whose supply gets limited during bouts of depression.
“More and more of us in modern life exist in a state of chronic stress, which depletes essential neurotransmitters in parts of the brain linked with depression and other mental health conditions. Ketamine can reverse this process and the symptoms that come with it. At low doses, ketamine relaxes the mind and gives it a break from cyclical self-defeating and limiting thoughts and stories.”
Soft Reboot Wellness spokesperson
Ketamine was first approved by the FDA in the 1970s for use as an anesthetic medication. Subsequent research revealed it to possess other therapeutic benefits when administered intravenously. Known to initiate a form of reboot for the mind, the treatment center now provides Ketamine therapy to help interrupt the cycles of negative thoughts that are one of the hallmarks of major depressive disorders.
Soft Reboot Wellness’ Ketamine therapy stimulates the production of glutamate – the most prevalent neurotransmitter in the brain – to build healthier and stronger synapses between brain cells. All doses are administered by a licensed physician with specific training for DEA Schedule III medications. For patients who have a history of respiratory or cardiovascular issues, the clinic offers additional support via oxygen therapy and continuous end-tidal CO2 monitoring during the infusion procedure.
The treatment can help with conditions such as PTSD, OCD, post-partum depression, chronic pain, migraines, fibromyalgia, and alcohol dependence. Headed by founder Dr. Sara Herman MD – a board-certified anesthesiologist and graduate of the Harvard Medical School and Columbia University – the clinic takes an ethical and holistic approach to psychological therapy.
-
Psychedelics6 days ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics6 days ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Law & Regulation7 days ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research